We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

88 hedge funds and large institutions have $206M invested in Pacific Biosciences in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

10% more funds holding

Funds holding: 80 → 88 (+8)

5% more capital invested

Capital invested by funds: $197M → $206M (+$8.93M)

3% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 30

12% less call options, than puts

Call options by funds: $312K | Put options by funds: $355K

Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
30
Closed
10
Calls
$312K
Puts
$355K
Net Calls
-$43K
Net Calls Change
-$32K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$6.67M
2
Millennium Management
Millennium Management
New York
+$5.74M
3
OAM
Oxford Asset Management
United Kingdom
+$3.69M
4
BA
BlackRock Advisors
Delaware
+$3.38M
5
SIM
Spark Investment Management
New York
+$2.36M

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$8.13M
2
Invesco
Invesco
Georgia
-$3.17M
3
TC
TFS Capital
Pennsylvania
-$2.18M
4
RCM
Raging Capital Management
New Jersey
-$1.64M
5
California Public Employees Retirement System
California Public Employees Retirement System
California
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.17M -$95.7K -15,147 -6%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$1.09M +$491K +77,694 +62%
BIM
28
BlackRock Investment Management
Delaware
$932K +$72.6K +11,486 +7%
CS
29
Credit Suisse
Switzerland
$861K +$549K +86,914 +117%
Invesco
30
Invesco
Georgia
$805K -$3.17M -501,701 -77%
Deutsche Bank
31
Deutsche Bank
Germany
$722K +$340K +53,795 +66%
Renaissance Technologies
32
Renaissance Technologies
New York
$566K +$669K +105,766 New
WMSA
33
Weiss Multi-Strategy Advisers
New York
$535K -$126K -20,000 -17%
ProShare Advisors
34
ProShare Advisors
Maryland
$530K +$420K +66,400 +203%
Nomura Holdings
35
Nomura Holdings
Japan
$519K -$46.6K -7,372 -7%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$503K +$46.8K +7,400 +9%
AQR Capital Management
37
AQR Capital Management
Connecticut
$496K +$8.22K +1,300 +1%
CLOS
38
Compagnie Lombard Odier SCmA
Switzerland
$495K +$585K +92,500 New
Charles Schwab
39
Charles Schwab
California
$458K – – –
AllianceBernstein
40
AllianceBernstein
Tennessee
$420K – – –
TA
41
Teachers Advisors
New York
$401K – – –
RFC
42
Russell Frank Company
Washington
$395K -$245K -38,700 -30%
Los Angeles Capital Management
43
Los Angeles Capital Management
California
$386K +$455K +72,060 New
NFA
44
Nationwide Fund Advisors
Ohio
$375K -$496K -78,539 -53%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$366K -$3.92K -620 -0.9%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$343K +$406K +64,183 New
LOCB
47
Lombard Odier & Cie (Bahamas)
Bahamas
$321K +$379K +60,000 New
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$301K +$101K +15,940 +40%
NI
49
Numeric Investors
Massachusetts
$292K +$161K +25,500 +88%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$276K +$326K +51,607 New
1
2
3 4

PACB Hedge Fund Activity: Q1 2014 in Review

88 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q1 2014, worth a combined $206M — up 4.5% from $197M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PACB positions and 10 closed out — a net gain of 8 holders — while 31 added to existing stakes and 30 trimmed.

The largest buyer was Deerfield Management, adding an estimated $6.67M. The largest seller was BlackRock Institutional Trust, cutting an estimated $8.13M.

  • 88 institutional investors held Pacific Biosciences (PACB) as of Q1 2014, up from 80 in Q4 2013.
  • Funds reported $206M of Pacific Biosciences stock for Q1 2014, up 4.5% quarter-over-quarter.
  • 18 funds opened new Pacific Biosciences positions in Q1 2014 and 10 closed out, a net change of +8 holders.
  • The largest Pacific Biosciences buyer in Q1 2014 was Deerfield Management, an estimated $6.67M added.
  • The largest Pacific Biosciences seller in Q1 2014 was BlackRock Institutional Trust, an estimated $8.13M sold.

Based on aggregated 13F filings for Q1 2014.